Navigation Links
Eamonn Hobbs Joins the Board of Directors at Cappella
Date:2/17/2010

GALWAY, Ireland, February 17, 2010 /PRNewswire/ -- Cappella (http://www.cappella-med.com/), Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the addition of Mr. Eamonn Hobbs to the Board of Directors ( http://www.cappella-med.eu/index.php?option=com_content&view=article&id=181:bf-directors&catid=4). According to Mr. Wolfgang Oster, MD, PhD, Chairman of the Board and Managing Partner at PolyTechnos Venture-Partners GmbH, "Eamonn's wealth of expertise and solid track record of success in our medical device field makes him a formidable source of wisdom and judgement for the road ahead of Cappella. The company's commercial programs and global market expansion will greatly benefit from Mr Hobbs' insights."

Mr. Eamonn Hobbs, President, CEO, & Director of Delcath Systems, Inc. is an entrepreneurial senior executive with over 25 years of medical device experience and demonstrated success in profitable business creation, general management, sales and marketing and product development. When asked to comment on his recent appointment, Mr. Hobbs stated, "I am delighted to join Cappella's Board of Directors and support the cause of this company which is all about addressing a substantial unmet medical need. Whereas long under-diagnosed and under-served, bifurcational lesions have now attracted the much deserved attention of the medical community and I am convinced that Cappella has put the best team on the field to tackle the challenge. I am thrilled to work with Dr. Art Rosenthal and our Board of Directors to deliver this technology to patients in need."

About Cappella, Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial product, the Sideguard(R) (http://www.cappella-med.eu/index.php?option=com_content&view=article&id=1&Itronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary arteries first, rather than the main vessel. More importantly, it allows the preferred stent of choice for the main vessel. An optimal stent design specific to the anatomy of the sidebranch, combined with the qualities of Nitinol now provide a dynamic solution for treating sidebranch disease. Cappella Medical Devices Ltd., Galway, Ireland is the R&D and manufacturing subsidiary of Cappella, Inc. For more information, see: http://www.cappella-med.com.

(Due to the length of some of the URLs in this release, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

Links: Cappella : http://www.cappella-med.com/

SOURCE Cappella Inc.


'/>"/>
SOURCE Cappella Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
2. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
3. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
4. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
5. CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
6. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
7. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
8. Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
9. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
10. PFC Pharma Joins DATATRAKs CRO Connect Program
11. William Cork Joins Fenwal as Chief Technology Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
Breaking Medicine News(10 mins):